Faculty Logo

Print this Page
Professor Dr. / Ahmed Sherif Attia
Microbiology and Immunology

Latest List of Publications

1. Amer MA, Ramadan MA, Attia AS, Wasfi R. Silicone Foley catheters impregnated with microbial indole derivatives inhibit crystalline biofilm formation by Proteus mirabilis. Frontiers in Cellular and Infection Microbiology 2022;12:1010625.
2. Saad MA, Eissa NM, Ahmed MA, ElMeshad AN, Laible G, Attia AS, et al. Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice. International Journal of Nanomedicine. 2022;17:3967-87.
3. Elsebaie MM, El-Din HTN, Abutaleb NS, Abuelkhir AA, Liang H-W, Attia AS, et al. Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin-and vancomycin-resistant Staphylococcus aureus. European Journal of Medicinal Chemistry. 2022:114204.
4. Abdel Moneim M, Abdelaziz DH, Ibrahim Nagy Y, Abdel Baki A, Attia AS, Sabry N. Rifaximin microbial resistance and its efficacy and safety as a secondary prophylaxis of hepatic encephalopathy in patients with hepatitis C virus-related cirrhosis. International Journal of Clinical Practice. 2021:e14807.
5. Elhosseiny NM, Samir TM, Ali AA, El-Kholy AA, Attia AS. Development of an Immunochromatographic Strip Using Conjugated Gold Nanoparticles for the Rapid Detection of Klebsiella pneumoniae Causing Neonatal Sepsis. Pharmaceutics. 2021;8(8):1141.
6. Mahdally NH, George RF, Kashef MT, Al-Ghobashy M, Murad FE, Attia AS. Staquorsin: A Novel Staphylococcus aureus Agr-Mediated Quorum Sensing Inhibitor Impairing Virulence in vivo Without Notable Resistance Development. Frontiers in Microbiology. 2021;12:700494.
7. Rizk SS, Elwakil WH, Attia AS. Antibiotic-Resistant Acinetobacter baumannii in Low-Income Countries (2000-2020): Twenty-One Years and Still below the Radar, Is It Not There or Can They Not Afford to Look for It? Antibiotics (Basel). 2021;10(7).
8. Amer MA, Wasfi R, Attia AS, Ramadan MA. Indole Derivatives Obtained from Egyptian Enterobacter sp. Soil Isolates Exhibit Antivirulence Activities against Uropathogenic Proteus mirabilis. Antibiotics (Basel). 2021;10(4):363.
9. Osama D, El-Mahallawy H, Mansour MT, Hashem A, Attia AS. Molecular Characterization of Carbapenemase-Producing Klebsiella pneumoniae Isolated from Egyptian Pediatric Cancer Patients Including a Strain with a Rare Gene-Combination of beta-Lactamases. Infection and Drug Resistance. 2021;14:335-48.
10. Mohamed SA, Samir TM, Helmy OM, Elhosseiny NM, Ali AA, El-Kholy AA, Attia AS. A Novel Surface-Exposed Polypeptide Is Successfully Employed as a Target for Developing a Prototype One-Step Immunochromatographic Strip for Specific and Sensitive Direct Detection of Staphylococcus aureus Causing Neonatal Sepsis. Biomolecules. 2020;10(11).
11. Hagras M, Abutaleb NS, Elhosseiny NM, Abdelghany TM, Omara M, Elsebaei MM, Alhashimi M, Norvil AB, Gutay MI, Gowher H, Attia AS, Seleem MN, Mayhoub AS. Development of Biphenylthiazoles Exhibiting Improved Pharmacokinetics and Potent Activity Against Intracellular Staphylococcus aureus. ACS Infectious Diseases. 2020;6(11):2887-900.
12. Elhosseiny NM, Elhezawy NB, Sayed RM, Khattab MS, El Far MY, Attia AS. Gamma-Glutamyltransferase as a Novel Virulence Factor of Acinetobacter baumannii Inducing Alveolar Wall Destruction and Renal Damage in Systemic Disease. The Journal of Infectious Diseases. 2020;222(5):871-9.
13. Nour El-Din HT, Elhosseiny NM, El-Gendy MA, Mahmoud AA, Hussein MM, Attia AS. A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform. Biomolecules. 2020;10(3):435.
14. Gowayed MA, Rothe K, Rossol M, Attia AS, Wagner U, Baerwald C, El-Abhar HS, Refaat R. The role of alpha7nAChR in controlling the anti-inflammatory/anti-arthritic action of galantamine. Biochemical Pharmacology. 2019;170:113665.
15. El Far MY, El-Mahallawy HA, Attia AS. Tracing the dissemination of the international clones of multidrug-resistant Acinetobacter baumannii among cancer patients in Egypt using the PCR-based open reading frame typing (POT) method. Journal of Global Antimicrobial Resistance. 2019;19:210-5.
16. Choucry AM, Al-Shorbagy MY, Attia AS, El-Abhar HS. Pharmacological Manipulation of Trk, p75NTR, and NGF Balance Restores Memory Deficit in Global Ischemia/Reperfusion Model in Rats. Journal of Molecular Neuroscience. 2019;68(1):78-90.
17. Elhosseiny NM, Elhezawy NB, Attia AS. Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance. Microbial Pathogenesis. 2019;128:20-7.
18. Elhosseiny NM, Attia AS. Acinetobacter: an emerging pathogen with a versatile secretome. Emerging Microbes & Infections. 2018;7(1):33.
19. Kamel AM, Farid SF, Attia AS, El Raziky M. Association of vitamin D binding protein polymorphisms with response to therapy in Egyptian chronic hepatitis C patients. Journal of Infection in Developing Countries. 2017;11(10):781-90.
20. Nagy YI, Hussein MMM, Ragab YM, Attia AS. Isogenic mutations in the Moraxella catarrhalis CydDC system display pleiotropic phenotypes and reveal the role of a palindrome sequence in its transcriptional regulation. Microbiological Research. 2017;202:71-9.
21. Samir R, Hussein SH, Elhosseiny NM, Khattab MS, Shawky AE, Attia AS. Adaptation to Potassium-Limitation Is Essential for Acinetobacter baumannii Pneumonia Pathogenesis. The Journal of Infectious Diseases. 2016;214(12):2006-13.
22. Elhosseiny NM, El-Tayeb OM, Yassin AS, Lory S, Attia AS. The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization. International Journal of Medical Microbiology. 2016;306(8):633-41.
23. Al-Ghobashy MA, Hassan SA, Abdelaziz DH, Elhosseiny NM, Sabry NA, Attia AS, El-Sayed MH. Development and validation of LC-MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphism. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences. 2016;1038:88-94.
24. Hennawy MG, Elhosseiny NM, Sultan H, Abdelfattah W, Akl Y, Sabry NA, Attia AS. The effect of alpha1-antitrypsin deficiency combined with increased bacterial loads on chronic obstructive pulmonary disease pharmacotherapy: A prospective, parallel, controlled pilot study. Journal of Advanced Research. 2016;7(6):1019-28.
25. Abdelaziz DH, Elhosseiny NM, Khaleel SA, Sabry NA, Attia AS, El-Sayed MH. Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. 2016;63(9):1539-45.
26. Attia AS. Accurate diagnosis is paving the road to better clinical outcomes (Editorial). Archives of Clinical Microbiology. 2016;7(4):e008.
27. Yassin GM, Amin MA, Attia AS. Immunoinformatics Identifies a Lactoferrin Binding Protein A Peptide as a Promising Vaccine With a Global Protective Prospective Against Moraxella catarrhalis. The Journal of Infectious Diseases. 2016;213(12):1938-45.
28. Ali MA, El-Abhar HS, Kamel MA, Attia AS. Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug. PloS One. 2015;10(8):e0134648.
29. Sabiel EA, Abdel-fattah AM, Nashy EHA, Hussein MM, Attia AS. Novel Keratinase Enzyme from Cyberlindnera fabianii NRC3 Aza with Promising Keratin-Biodegradation and Hide-Dehairing Activities. Journal of Indian Leather Technologists' Association. 2015;65(8):17-25.
30. Mahmoud-Awny M, Attia AS, Abd-Ellah MF, El-Abhar HS. Mangiferin Mitigates Gastric Ulcer in Ischemia/ Reperfused Rats: Involvement of PPAR-gamma, NF-kappaB and Nrf2/HO-1 Signaling Pathways. PloS One. 2015;10(7):e0132497.
31. Abdel-fattah AM, Nashy E-SH, Sabiel E-TA, Hussien MM, Attia AS. Novel Keratinolytic Activity of Cyberlindnera fabianii Nrc3 Aza as A Plant Growth Promoting Agent (PGPA). International Journal of Applied Sciences and Biotechnology. 2015;3(4):609-18.
32. Elfaky MA, Yassien MA, Attia AS, Mansy MS, Ashour MS. Antimicrobial resistance pattern of biofilm forming Pseudomonas aeruginosa isolated from patients with nasogastric and endotracheal tubes. World Journal of Pharmaceutical Sciences. 2015;3(3):401-6.
33. Elhosseiny NM, Amin MA, Yassin AS, Attia AS. Acinetobacter baumannii universal stress protein A plays a pivotal role in stress response and is essential for pneumonia and sepsis pathogenesis. International Journal of Medical Microbiology. 2015;305(1):114-23.
34. Joslin SN, Pybus C, Labandeira-Rey M, Evans AS, Attia AS, Brautigam CA, Hansen EJ. A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors. Infection and Immunity. 2015;83(1):146-60.
35. Khalil MA, Azzazy HM, Attia AS, Hashem AG. A sensitive colorimetric assay for identification of Acinetobacter baumannii using unmodified gold nanoparticles. Journal of Applied Microbiology. 2014;117(2):465-71.
36. Elfaky MA, Yassien MA, Attia AS, Mansy MS, Ashour MS. Microbiological studies on resistance patterns of antimicrobial agents among Gram negative respiratory tract pathogens. African Journal of Microbiology Research 2014;8(27):2583-91.
37. Fouad M, Attia AS, Tawakkol WM, Hashem AM. Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. International Journal of Infectious Diseases. 2013;17(12):e1252-4.
38. Attia AS, Cassat JE, Aranmolate SO, Zimmerman LJ, Boyd KL, Skaar EP. Analysis of the Staphylococcus aureus abscess proteome identifies antimicrobial host proteins and bacterial stress responses at the host-pathogen interface. Pathogens and Disease. 2013;69(1):36-48.
39. Wakeman CA, Hammer ND, Stauff DL, Attia AS, Anzaldi LL, Dikalov SI, Calcutt MW, Skaar EP. Menaquinone biosynthesis potentiates haem toxicity in Staphylococcus aureus. Molecular Microbiology. 2012;86(6):1376-92.
40. Attia AS, Schroeder KA, Seeley EH, Wilson KJ, Hammer ND, Colvin DC, Manier ML, Nicklay JJ, Rose KL, Gore JC, Caprioli RM, Skaar EP.. Monitoring the inflammatory response to infection through the integration of MALDI IMS and MRI. Cell Host & Microbe. 2012;11(6):664-73.
41. Elghanam MS, Attia AS, Shoeb HA, Hashem AE. Expression and purification of hepatitis B surface antigen S from Escherichia coli; a new simple method. BMC Research Notes. 2012;5:125.
42. Elhabibi TM, Attia AS, Hashem AM, Ashour MS. Characterization of Bacillus cereus and Staphylococcus aureus strains isolated from food and food products retailed in the Egyptian Markets. New Egyptian Jouranl of Microbiology. 2012;31:40-52.
43. Attia AS. Archives of Clinical Microbiology: New Vision (Editorial). Archives of Clinical Microbiology. 2010;1(2):1.
44. Torres VJ, Attia AS, Mason WJ, Hood MI, Corbin BD, Beasley FC, Anderson KL, Stauff DL, McDonald WH, Zimmerman LJ, Friedman DB, Heinrichs DE, Dunman PM, Skaar EP. Staphylococcus aureus Fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infection and Immunity. 2010;78(4):1618-28.
45. Attia AS, Benson MA, Stauff DL, Torres VJ, Skaar EP. Membrane damage elicits an immunomodulatory program in Staphylococcus aureus. PLoS Pathogens. 2010;6(3):e1000802.
46. Attia AS, Sedillo JL, Hoopman TC, Liu W, Liu L, Brautigam CA, Hansen EJ. Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis. BMC Microbiology. 2009;9:207.
47. Marzouk DS, Attia AS, Hamouda HM, Hashem AM, Shoeb HA. Comparative study of TEM & SHV β-lactamase genes in Klebsiella pneumoniae isolates. Egyptian Journal of Biomedical Sciences. 2009;29:299-309.
48. Brooks MJ, Sedillo JL, Wagner N, Laurence CA, Wang W, Attia AS, Hansen E J, Gray-Owen SD. Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function. Infection and Immunity. 2008;76(11):5330-40.
49. Brooks MJ, Sedillo JL, Wagner N, Wang W, Attia AS, Wong H, Laurence CA, Hansen EJ, Gray-Owen SD. Moraxella catarrhalis binding to host cellular receptors is mediated by sequence-specific determinants not conserved among all UspA1 protein variants. Infection and Immunity. 2008;76(11):5322-9.
50. Attia AS, Sedillo JL, Wang W, Liu W, Brautigam CA, Winkler W, Hansen EJ. Moraxella catarrhalis expresses an unusual Hfq protein. Infection and Immunity. 2008;76(6):2520-30.
51. Wang W, Pearson MM, Attia AS, Blick RJ, Hansen EJ. A UspA2H-negative variant of Moraxella catarrhalis strain O46E has a deletion in a homopolymeric nucleotide repeat common to uspA2H genes. Infection and Immunity. 2007;75(4):2035-45.
52. Attia AS, Hansen EJ. A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein. Journal of Bacteriology. 2006;188(22):7840-52.
53. Attia AS, Ram S, Rice PA, Hansen EJ. Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infection and Immunity. 2006;74(3):1597-611.
54. Wang W, Attia AS, Liu L, Rosche T, Wagner NJ, Hansen EJ. Development of a shuttle vector for Moraxella catarrhalis. Plasmid. 2006;55(1):50-7.
55. Attia AS, Lafontaine ER, Latimer JL, Aebi C, Syrogiannopoulos GA, Hansen EJ. The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance. Infection and Immunity. 2005;73(4):2400-10.
56. Salama AA, Hosny AMS, Ahmady AM, Abdel-Hamid AA, Hussein ASM. Susceptibility of certain nosocomial pathogens to certain antibiotics and biocides commonly used in Egyptian hospitals. New Egyptian Journal of Microbiology. 2004;8:274-99.
Copyright © All rights reserved; Faculty of Pharmacy, Cairo University | Kasr El-Aini, Cairo 11562, Egypt
Contact Us | Phone: (00202) 23639307 - 23624917 - 2363245 | Fax: 23628246